Accelerator Corp. logo

Accelerator Corp.

North America, Washington, United States, Seattle

Description

Accelerator is a biotechnology investment and management company.

Investor Profile

Accelerator Corp. has made 4 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series A (75%)
  • Series Unknown (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Health Diagnostics
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Accelerator Corp. frequently co-invest with?

Alexandria
North America, California, United States, San Francisco
Co-Investments: 1
Alexandria Real Estate Equities
North America, California, United States, Pasadena
Co-Investments: 1
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Washington Research Foundation
North America, Washington, United States, Seattle
Co-Investments: 3
Johnson & Johnson Robotics and Digital Solutions
North America, New Jersey, United States, New Brunswick
Co-Investments: 2
WuXi AppTec
Asia, Shanghai, China, Shanghai
Co-Investments: 2
WF
North America, Washington, United States, Seattle
Co-Investments: 2
AbbVie Biotech Ventures
North America, Illinois, United States, North Chicago
Co-Investments: 2
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 3

What are some of recent deals done by Accelerator Corp.?

Rodeo Therapeutics

Seattle, Washington, United States

Rodeo Therapeutics is a developer of small-molecule therapies designed to promote regeneration and repair of multiple tissue types.

BiotechnologyPharmaceuticalTherapeutics
Series AJul 25, 2017
Amount Raised: $5,900,000
ApoGen Biotechnologies

Seattle, Washington, United States

ApoGen Biotechnologies, Inc. is a biotechnology company focused on the development of a new class of therapeutics.

BiotechnologyHealth CarePharmaceutical
Series ADec 12, 2016
Amount Raised: $7,000,000
NanoString Technologies

Seattle, Washington, United States

NanoString Technologies provides a life science tools platform for a variety of basic research, translational medicine and IVD applications.

BiotechnologyHealth DiagnosticsMedical
Series UnknownMay 13, 2013
Amount Raised: $150,000
Oncofactor

Seattle, Washington, United States

Oncofactor develops cancer therapeutics that disrupt signaling pathways between tumors and the immune system.

BiotechnologyHealth CareTherapeutics
Series AAug 2, 2011
Amount Raised: $2,100,000